— Know what they know.
Not Investment Advice
Also trades as: NVV1.F (FSX) · $vol 0M

NVAX NASDAQ

Novavax, Inc.
1W: -4.0% 1M: +6.3% 3M: -2.4% YTD: +25.9% 1Y: +16.9% 3Y: +17.5% 5Y: -93.2%
$9.21
+0.23 (+2.56%)
 
Weekly Expected Move ±10.7%
$7 $8 $9 $10 $11
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 59 · $1.5B mcap · 141M float · 3.36% daily turnover · Short 45% of daily vol

Cash Flow Trends

Operating Cash Flow
-$245M -180.3% ▼
Capital Expenditures
$6M +57.4% ▲
5Y CAGR: -36.7%
Free Cash Flow
-$250M -149.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$5M +0.0% ▲
Net Change in Cash
-$289M -650.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$1.7B-$658M-$545M-$187M$440M
Depreciation & Amort.$13M$29M$41M$48M$28M
Stock-Based Comp.$184M$130M$85M$48M$36M
Change in Working Capital$1.7B-$361M-$377M$48M-$888M
Other Non-Cash Items$137M$444M$81M-$45M$139M
Operating Cash Flow$323M-$416M-$714M-$87M-$245M
— Investing Activities —
Capital Expenditures-$57M-$93M-$59M-$15M-$6M
Acquisitions (Net)$57M$0$0$193M$0
Investment Purchases-$2M$0$0-$826M-$445M
Investment Sales$160M$0$0$444M$354M
Other Investing-$57M$0$0$0$19M
Investing Cash Flow$100M-$93M-$59M-$204M-$78M
— Financing Activities —
Net Debt Issuance-$128M$82M-$352M-$4M$33M
Stock Repurchased$0$0$0$0-$5M
Dividends Paid$0$0$0$0$0
Other Financing$25M-$6M-$4M$1M$0
Financing Cash Flow$462M$325M$4M$261M$28M
Net Change in Cash$880M-$179M-$765M-$39M-$289M
Cash End of Period$1.5B$1.3B$584M$545M$256M
Free Cash Flow$265M-$509M-$773M-$100M-$250M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms